We are a research and development organization specializing in advanced battery technologies, designing, developing and testing the batteries of the future for nearly 30 years. We offer partnerships based on trust. They include framework collaboration agreements with clients based on their strategic R&D plans, or joint investments in strategic areas. We also advise and partner with companies in R&D&I projects that will let them incorporate or develop their own technology, allowing for heightened competitiveness. With the capacity to develop complete products and processes, we offer services that include material validation, pilot manufacturing, pack engineering, digitalization, battery testing (including post-mortem analysis), as well as battery recycling and second-life applications. Our areas of expertise include: Cell development, Battery Systems, Digitalization, Battery Testing and Battery Circularity. | We are a European research and development organization specializing in advanced battery technologies, designing, developing, producing and testing the batteries of the future for nearly 30 years. Our expertise positions us among the top 5 R&D Centers in Europe for Battery Development and Production. We work with different technologies:Advanced Lithium ion (high density of energy)Advanced Lithium ion (high density of power)LiS (RAPTOR). Our solution for the defense and military sectorsLi-Metal (SSB) We also provide Battery Modelling & Postmortem services.Our knowledge is highly focused on real market needs, and our results provide applicable solutions to the real-world challenges our clients face. If you are looking for a gateway to Europe, we can be your partner. Let`s talk at Booth 2226!
CI&T
CI&T (NYSE: CINT) is a global technology transformation specialist for retailers, CPG brands, and quick-serve restaurants. With a presence in ten countries and a 30-year track record of helping clients navigate change, CI&T has deep expertise in AI enablement, unified commerce solutions, application modernization, and data strategy — building personalized customer experiences for omnichannel brands. | At CI&T (NYSE: CINT), we don’t just follow trends—we set them. As global tech transformation specialists, we help hospitals and payers revolutionize the healthcare industry. With our expansive team of over 7,000 digital engineers, designers, and strategists, we empower organizations to leap into the future of digital health by transforming patient experiences with composable solutions, optimizing operations with AI, enabling seamless data interoperability, and driving secure cloud modernization. | CI&T (NYSE: CINT) is a tech-integrated business solutions partner with 30 years of experience guiding large enterprises. A leader in innovation, the company drives the future of digital health via composable solutions, AI optimization, data interoperability, and secure cloud modernization. As a trusted LATAM nearshore provider, CI&T operates globally with a workforce of over 8,000 professionals across 11 countries, delivering scalable digital transformation and continuous adaptability.
Choose New Jersey
Choose New Jersey is a privately funded 501(c)(3) economic development organization with a mission to stimulate job creation and attract capital investment to New Jersey. Choose New Jersey markets New Jersey, both domestically and internationally, as the best place to grow a business in the United States. Knowledgeable, experienced staff, supported by a network of state agencies and private partners, provide free, confidential assistance to guide companies in establishing operations in New Jersey. By harnessing the power of business, labor, academic, and government leaders, Choose New Jersey enables growth across all sectors of the state’s economy, aspiring to build a stronger and more prosperous New Jersey for all. To learn more, visit choosenj.com. | Choose New Jersey is the State’s leading non-profit business attraction organization. We harness the collective power of New Jersey’s business, government, labor, and academic sectors to expand New Jersey’s economy. We work globally, using our marketing expertise, concierge business development services, deep knowledge of the State, and convening power in collaboration with State government to empower businesses, entrepreneurs, leaders, and innovators to make New Jersey their home. We are a privately funded 501(c)(3) organization. To learn more, visit choosenj.com. | x | Choose New Jersey is the state’s leading non-profit business attraction organization. We harness the collective power of New Jersey’s business, government, labor, and academic sectors to expand New Jersey’s economy. We work globally, using our marketing expertise, concierge business development services, deep knowledge of the state, and convening power, in collaboration with state government, to empower businesses, entrepreneurs, leaders, and innovators to make New Jersey their home.
Chois Technology Co., Ltd.
CHOISTECHNOLOGY CO., LTD. develops IoMT-based medical devices, including ThermoSafer, a non-invasive wireless core body temperature monitor for hospitals and home care. We enhance patient safety with continuous, accurate monitoring and smart healthcare innovation.
Cholangiocarcinoma Foundation
The Cholangiocarcinoma Foundation is a global organization dedicated to curing cholangiocarcinoma (bile duct cancer) and enhancing patients’ quality of life. Through innovative methodologies, partnerships, and support programs, CCF connects patients and caregivers to resources, mentors, and support groups, while also fostering scientific discovery through an annual research fellowship program.
Chitozan Health LLC
Chitozan Health is an antimicrobial company seeking to commercialize antimicrobial materials that minimize the tendency for resistance to develop in bacteria and fungal threats. We are currently focused on launch of an advanced burn and wound gel in collaboration with the Medical University of South Carolina and the Chief of Burn Surgery Dr. Steven Kahn. Other products in stages of development are an antimicrobial flame-resistant textile finish, an anti-fungal barrier packaging coating, topical skin disease treatments, and an inhaled therapeutic for treatment of chronic lung infections caused by pseudomonas aeruginosa and mycobacteria.
China Chamber of International Commerce
China Chamber of International Commerce, or CCOIC, was established in 1988 with the approval of the State Council of the People’s Republic of China. Affiliated to China Council for the Promotion of International Trade (CCPIT), CCOIC is a nationwide chamber of commerce comprised of enterprises, groups and other business organizations that are engaged in international commercial activities in China. CCOIC also represents China in participating in the work of International Chamber of Commerce (ICC) with the name of ICC China. CCOIC adopts a membership system and its main responsibilities include: promoting economic and trade exchanges and cooperation between China and foreign countries; reflecting interest appeal of enterprises to international organizations and government departments of China and foreign countries on behalf of Chinese business community; participating in constitution and promotion of international trade rules; facilitating enterprises to participate in international competition and cooperation; safeguarding legitimate rights of its members, and actively advocating social responsibility and public welfare among business circles. By the end of 2021, CCOIC has 301,000 member enterprises, including most central SOEs, national financial institutions, a large number of well-known private enterprises and foreign-funded enterprises. CCOIC has become one of the most influential business associations in China. With the aim of building a hub-like chamber of commerce, CCOIC has institutional cooperation with other business associations from home and abroad, and provides services for its members and other enterprises including international exchange, industrial cooperation, legal advice, market information, exhibition planning, project investment and training. | China Chamber of International Commerce, or CCOIC, was established in 1988 with the approval of the State Council of the People’s Republic of China. Affiliated to China Council for the Promotion of International Trade (CCPIT), CCOIC is a nationwide chamber of commerce comprised of enterprises, groups and other business organizations that are engaged in international commercial activities in China. CCOIC also represents China in participating in the work of International Chamber of Commerce (ICC) with the name of ICC China. CCOIC adopts a membership system and its main responsibilities include: promoting economic and trade exchanges and cooperation between China and foreign countries; reflecting interest appeal of enterprises to international organizations and government departments of China and foreign countries on behalf of Chinese business community; participating in constitution and promotion of international trade rules; facilitating enterprises to participate in international competition and cooperation; safeguarding legitimate rights of its members, and actively advocating social responsibility and public welfare among business circles. Up to now, CCOIC has 351,000 member enterprises, including most central SOEs, national financial institutions, a large number of well-known private enterprises and foreign-funded enterprises. CCOIC has become one of the most influential business associations in China. With the aim of building a world-class chamber of commerce with Chinese characteristics, CCOIC has institutional cooperation with other business associations from home and abroad, and provides services for its members and other enterprises including international exchange, industrial cooperation, legal advice, market information, exhibition planning, project investment and training.
China Anti-Cancer Association
China Anti-Cancer Association (CACA) is a non-governmental and non-profit organization in the field of oncology in China. Founded in 1984, it has developed into the largest organization in cancer field with long history and great influence in China. Up to now, CACA has established local anti-cancer associations in all 31 provinces, cities, and autonomous regions across China, creating a network of 200 professional societies. With 162 organization members and over 800,000 individual members, CACA serves as a significant platform for academic exchanges, public education, promoting CACA Guidelines, and international cooperation in the field of oncology.